Chung Wu Investment Group »

Lexeo Therapeutics shares owned by Chung Wu Investment Group

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Chung Wu Investment Group from 13F filings

Historical chart of Chung Wu Investment Group investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Chung Wu Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Chung Wu Investment Group

Quarter filed Position value Share count Share price at filing
2026-06-30 $4.7k 1.0k 4.66

More positions owned by Chung Wu Investment Group

Ishares Tr Core S&p500 Etf Core S&p500 Etf (IVV)
Micron Technology (MU)
Neos S&p 500 High Income Etf Neos S&p 500 Hi (SPYI)
Neos Nasdaq 100 High Income Etf Nasdaq 100 High (QQQI)
State Street Spdr Dow Jones Industrial Average Etf Ut Ser 1 (DIA)
Microsoft Corporation (MSFT)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
NVIDIA Corporation (NVDA)
Eaton Vance Enhanced Equity Incm. Fd. II (EOS)
State Street Spdr S&p 500 Etf Trust Tr Unit (SPY)
Ge Vernova (GEV)
MasTec (MTZ)
Antero Midstream Corp antero midstream (AM)
Space Exploration Techn Corporation Class A Com Stk Class A Com Stk (SPCX)

View all positions for Chung Wu Investment Group

Top funds holding Lexeo Therapeutics

Paradigm Biocapital Advisors
BlackRock
Affinity Asset Advisors
RA Capital Management
Henderson Group
Vestal Point Capital
Frazier Life Sciences Management
Citadel Advisors
OrbiMed Advisors
State Street Corporation
Vanguard Capital Management
Woodline Partners
Goldman Sachs Group
venBio Select Advisor
Point72 Asset Management

View all funds holding Lexeo Therapeutics